Stonehenge Growth Capital

investment firm

About

Stonehenge Growth Capital is the private equity and venture capital arm of Stonehenge Capital

Details

Industries
Finance,Venture Capital
Founded date
Jan 1, 1999
Operating Status
Active
Investor Type
Venture Capital

Stonehenge Growth Capital, LLC ("SGC") manages the venture capital, private equity and mezzanine investment activities of Stonehenge Capital Company, LLC ("SCC"). The executive management and key professionals of Banc One Capital Markets formed SCC in 1999 as a spinoff from Bank One. Stonehenge Growth Capital manages over $677 million across venture capital, private equity and debt funds, operating out of five regional offices across the United States.

Stonehenge is a perfect match for companies with long-term vision focused on pursuing new, exciting and high growth opportunities, and for entrepreneurs with a passion for innovation and achievement.

Their flexible and creative financing approach sets their investments apart. They seek to create customized financing solutions for each portfolio company based on its unique strategic and financial plan.

Investments

Number of Investments
Number of Lead Investments
6
3
Stonehenge Growth Capital has made 6 investments. Their most recent investment was on Aug 6, 2018, when Clerio Vision raised $2.95M.
Date Company Name
Round Money Raised Industry Lead Investor
Aug 6, 2018 Clerio Vision
Funding Round $2.95M Biotechnology
Oct 1, 2017 Wellinks
Series Unknown $3.25M Fitness
Aug 10, 2017 PosiGen
Series Unknown $5M Clean Energy Yes
Convertable Note $1M Advertising Yes
Series Unknown $5.50M Application Performance Management Yes

Employee Profiles

Number of Employee Profiles
2
Stonehenge Growth Capital has 2 current employee profiles, including Executive Charles E. Haberkorn

Exits

Stonehenge Growth Capital has had 3 exits. Stonehenge Growth Capital most notable exits include The Big Willow, Inc. ,   iCardiac Technologies

Date Company Name Exit Type Industry
Dec 6, 2018 The Big Willow, Inc. M&A Advertising Detail
Dec 4, 2017 iCardiac Technologies M&A Biopharma Detail
Jan 25, 2016 PCC Technology Group M&A Application Performance Management Detail